Stay updated on Ubrogepant Clinical Trial
Sign up to get notified when there's something new on the Ubrogepant Clinical Trial page.

Latest updates to the Ubrogepant Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice about government funding lapse and the earlier Revision: v3.4.1.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded a government funding lapse notice and updated to Revision: v3.4.1; removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedUI changes include a new 'Show glossary' toggle, capitalization tweaks to labels (for example, 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a new version label 'Revision: v3.4.0' replacing 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No substantive changes to the study details or related content are evident.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (Revision: v3.3.3) and removed the separate per-state location entries.SummaryDifference2%

- Check91 days agoChange DetectedEditorial notes were updated to clarify that publications are automatically filled from PubMed and to display the current revision (v3.3.2). The old description of PubMed-listed publications and the previous revision (v3.2.0) were removed.SummaryDifference0.1%

Stay in the know with updates to Ubrogepant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ubrogepant Clinical Trial page.